7Baggers
 CytomX Therapeutics Hits New 52-Week High at $3.28  Markets Mojo Wed, 01 Oct 2025 18:49:08 GMT
 cytomx therapeutics (nasdaq:ctmx) shares up 8.5% - should you buy?  MarketBeat Mon, 29 Sep 2025 19:56:14 GMT
 CytomX Therapeutics Hits New 52-Week High of $3.25, Up 77.91%  Markets Mojo Mon, 29 Sep 2025 16:22:07 GMT
 cytomx (ctmx) shares surge on analyst coverage and drug potentia  GuruFocus Fri, 26 Sep 2025 12:39:31 GMT
 Why CytomX Therapeutics Stock Was Skyrocketing This Week  The Motley Fool Fri, 26 Sep 2025 12:08:34 GMT
 published on: 2025-09-25 10:44:57  metal.it Thu, 25 Sep 2025 08:45:45 GMT
 cantor fitzgerald forecasts ctmx fy2025 earnings  MarketBeat Tue, 23 Sep 2025 10:40:33 GMT
 ctmx: cantor fitzgerald initiates coverage with overweight ratin  GuruFocus Mon, 22 Sep 2025 13:19:42 GMT
 cytomx therapeutics (nasdaq:ctmx) now covered by barclays  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 CytomX Therapeutics (CTMX) Initiated with a Buy at Barclays  The Globe and Mail Sat, 20 Sep 2025 08:30:00 GMT
 cytomx therapeutics (nasdaq:ctmx) now covered by barclays  MarketBeat Sat, 20 Sep 2025 07:00:00 GMT
 cytomx therapeutics (nasdaq:ctmx) raised to strong-buy at barclays  MarketBeat Fri, 19 Sep 2025 11:22:19 GMT
 barclays upgrades cytomx therapeutics (nasdaq:ctmx) to strong-buy  MarketBeat Fri, 19 Sep 2025 11:22:19 GMT
 analyst upgrade: barclays assumes coverage of ctmx at overweight  GuruFocus Wed, 17 Sep 2025 12:04:25 GMT
 Barclays initiates CytomX Therapeutics stock with Overweight rating  Investing.com Wed, 17 Sep 2025 07:00:00 GMT
 CytomX Therapeutics assumed with an Overweight at Barclays  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 cytomx at morgan stanley conference: innovative oncology advances  Investing.com Wed, 10 Sep 2025 07:00:00 GMT
 published on: 2025-09-09 06:04:45  beatles.ru Tue, 09 Sep 2025 03:05:15 GMT
 published on: 2025-09-03 09:30:47  Newser Wed, 03 Sep 2025 14:30:47 GMT
 published on: 2025-09-03 13:30:24  beatles.ru Wed, 03 Sep 2025 10:32:09 GMT
 published on: 2025-08-30 13:07:08  Newser Sat, 30 Aug 2025 18:07:08 GMT
 published on: 2025-08-29 11:44:05  Newser Fri, 29 Aug 2025 16:44:05 GMT
 biotech premarket movers: cytomx, aevi, esperion  TheStreet Fri, 29 Aug 2025 03:42:13 GMT

CytomX Therapeutics, Inc
(NASDAQ:CTMX) 

CTMX stock logo

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (AD...

Full Time Employees: 158
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends